Skip to main content

Table 1 Baseline demographics of patients

From: Characteristics and longitudinal progression of chronic obstructive pulmonary disease in GOLD B patients

Demographic

n = 370

Gender (% Male)

65

Age (years)

70.2 (8.8)

Smoking status (Current %)

30.0

Pack years

46.0 [10.0–220.0]

BMI (kg/m2)

26.2 [15.6–49.2]

Exacerbations (1 year prior)

1.0 [0.0–15.0]

Inhaled steroid use %

78.8

Oral steroid use %

3.8

LABA use %

70.7

LAMA use %

75.0

Azithromycin use %

3.5

Post BD FEV1 (L)

1.4 (0.6)

Post BD FEV1 %

57.0 [20.0–117.0]

Post BD Ratio

0.5 [0.2–0.8]

GOLD A n (%)

34 (9.2)

GOLD B n (%)

107 (28.9)

GOLD C n (%)

12 (3.2)

GOLD D n (%)

217 (58.7)

  1. Summaries are presented as percentages, Mean (SD) or Median [Range] as appropriate
  2. Definitions of abbreviations; BMI body mass index, LABA long acting beta agonist, LAMA long acting muscarinic antagonist, Post BD post bronchodilator, FEV 1 forced expired volume in first second